Palisade Bio (PALI) director adds 45,000 shares through July open-market buys
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PALISADE BIO, INC. director Robert Baltera Jr. reported two open-market purchases of Common Stock. He bought 20,000 shares on July 8, 2026 at a weighted average price of $1.9899 per share, and 25,000 shares on July 9, 2026 at a weighted average price of $1.9560 per share. Following these transactions, he directly holds 461,904 shares. Each daily price is a weighted average of multiple trades within the stated intraday price ranges.
Positive
- None.
Negative
- None.
Insights
Director increased direct ownership through two open-market stock purchases.
Director Robert Baltera Jr. executed two open-market purchases of PALISADE BIO common stock, acquiring a total of 45,000 shares across July 8–9, 2026. The trades were made at weighted average prices of $1.9899 and $1.9560 per share, based on multiple executions within disclosed intraday ranges.
After these transactions, Baltera directly holds 461,904 shares of common stock. The filing shows only net purchases, with no concurrent sales or derivative exercises, and there is no indication that the trades were executed under a Rule 10b5-1 trading plan in the provided text.
Insider Trade Summary
Net Buyer: 45,000 shares ($88,698)
Net Buy
2 txns
Insider
Baltera Robert Jr.
Role
null
Bought
45,000 shs ($89K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 25,000 | $1.956 | $49K |
| Purchase | Common Stock | 20,000 | $1.9899 | $40K |
Holdings After Transaction:
Common Stock — 461,904 shares (Direct, null)
Footnotes (1)
- The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9298 to $1.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Key Figures
Shares purchased July 8, 2026: 20,000 shares
Price per share July 8, 2026: $1.9899
Shares purchased July 9, 2026: 25,000 shares
+2 more
5 metrics
Shares purchased July 8, 2026
20,000 shares
Open-market purchase of Common Stock at weighted average price
Price per share July 8, 2026
$1.9899
Weighted average purchase price for 20,000 shares
Shares purchased July 9, 2026
25,000 shares
Open-market purchase of Common Stock at weighted average price
Price per share July 9, 2026
$1.9560
Weighted average purchase price for 25,000 shares
Shares held after transactions
461,904 shares
Director’s direct ownership of Palisade Bio Common Stock after reported trades
Key Terms
open-market purchase, weighted average price, beneficial ownership
3 terms
open-market purchase financial
"transaction_action is described as an open-market purchase of Common Stock"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"full information regarding the number of shares purchased at each separate price"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider activity did PALISADE BIO (PALI) report for Robert Baltera Jr.?
PALISADE BIO reported that director Robert Baltera Jr. made two open-market purchases of Common Stock on July 8 and 9, 2026, totaling 45,000 shares acquired directly.
Were the PALISADE BIO (PALI) insider purchases by Robert Baltera Jr. open-market transactions?
Yes. Both transactions reported for July 8 and 9, 2026 are coded “P” and described as open-market purchases of PALISADE BIO Common Stock.
How are the reported prices for Robert Baltera Jr.’s PALISADE BIO (PALI) trades calculated?
The prices $1.9899 and $1.9560 per share are weighted average prices, based on multiple trades within intraday ranges disclosed in the Form 4 footnotes.